• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化脓性汗腺炎:快速证据回顾。

Hidradenitis Suppurativa: Rapid Evidence Review.

机构信息

University of Kansas School of Medicine-Wichita, Wichita, KS, USA.

出版信息

Am Fam Physician. 2019 Nov 1;100(9):562-569.

PMID:31674740
Abstract

Hidradenitis suppurativa is a chronic folliculitis affecting intertriginous areas. Onset generally occurs in young adulthood to middle adulthood (18 to 39 years of age). Females and blacks are more than twice as likely to be affected. Additional risk factors include family history, smoking, and obesity. Hidradenitis suppurativa is associated with several comorbidities, including diabetes mellitus and Crohn disease. The clinical presentation of hidradenitis suppurativa ranges from rare, mild inflammatory nodules to widespread abscesses, sinus tracts, and scarring. Quality of life is often affected, and patients should be screened for depression. Treatment includes wearing loose-fitting clothes, losing weight if overweight, and smoking cessation. Topical clindamycin alone can be effective for patients with mild disease. Patients with moderate disease can be treated with oral antibiotics, such as tetracyclines, in addition to topical clindamycin. Adalimumab, a tumor necrosis factor alpha inhibitor, is effective for patients with moderate to severe hidradenitis suppurativa. Surgical procedures are often necessary for definitive treatment and include local procedures, such as punch debridement and unroofing/deroofing. Wide excision is indicated for patients with severe, extensive disease and scarring.

摘要

化脓性汗腺炎是一种影响皱褶部位的慢性毛囊炎。发病通常发生在青年期到中年期(18 岁至 39 岁)。女性和黑人的发病率是男性和白人的两倍以上。其他危险因素包括家族史、吸烟和肥胖。化脓性汗腺炎与多种合并症有关,包括糖尿病和克罗恩病。化脓性汗腺炎的临床表现从罕见的轻度炎症性结节到广泛的脓肿、窦道和瘢痕形成不等。生活质量通常受到影响,患者应接受抑郁筛查。治疗包括穿着宽松的衣服、超重者减肥和戒烟。对于轻度疾病的患者,单独使用局部克林霉素可能有效。对于中度疾病的患者,可以在局部使用克林霉素的基础上使用口服抗生素,如四环素。对于中重度化脓性汗腺炎患者,肿瘤坏死因子-α抑制剂阿达木单抗有效。手术通常是必要的,包括局部手术,如打孔清创术和切开引流术。对于严重、广泛病变和瘢痕形成的患者,建议进行广泛切除术。

相似文献

1
Hidradenitis Suppurativa: Rapid Evidence Review.化脓性汗腺炎:快速证据回顾。
Am Fam Physician. 2019 Nov 1;100(9):562-569.
2
Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.皮肤科和性病科在莫斯塔尔临床医院用阿达木单抗治疗两例化脓性汗腺炎。
Acta Dermatovenerol Croat. 2021 Jul;29(2):108-110.
3
Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.化脓性汗腺炎/反向痤疮:治疗优化的实用框架 - HS ALLIANCE 工作组的系统评价和建议。
J Eur Acad Dermatol Venereol. 2019 Jan;33(1):19-31. doi: 10.1111/jdv.15233. Epub 2018 Oct 23.
4
Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.基于欧洲化脓性汗腺炎指南的化脓性汗腺炎/反向性痤疮循证治疗方法
Rev Endocr Metab Disord. 2016 Sep;17(3):343-351. doi: 10.1007/s11154-016-9328-5.
5
Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study.阿达木单抗与利福平联合克林霉素治疗中度至重度化脓性汗腺炎的回顾性研究
J Drugs Dermatol. 2019 May 1;18(5):437-438.
6
[CME Dermatology 23: Hidradenitis suppurativa].[继续医学教育皮肤科23:化脓性汗腺炎]
Praxis (Bern 1994). 2021;110(7):363-372. doi: 10.1024/1661-8157/a003693.
7
Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.用阿达木单抗治疗重度顽固性化脓性汗腺炎。
J Dtsch Dermatol Ges. 2009 Feb;7(2):139-41. doi: 10.1111/j.1610-0387.2008.06918.x.
8
[CME Dermatology 23/Answers: Hidradenitis suppurativa].[继续医学教育皮肤科23/答案:化脓性汗腺炎]
Praxis (Bern 1994). 2021 Jun;110(8):471-472. doi: 10.1024/1661-8157/a003694.
9
Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.克林霉素与克林霉素加利福平治疗化脓性汗腺炎:临床和超声观察。
J Am Acad Dermatol. 2019 May;80(5):1314-1321. doi: 10.1016/j.jaad.2018.11.035. Epub 2018 Nov 28.
10
Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa.外用克林霉素与全身应用四环素治疗化脓性汗腺炎的比较。
J Am Acad Dermatol. 1998 Dec;39(6):971-4. doi: 10.1016/s0190-9622(98)70272-5.

引用本文的文献

1
Comparing antibiotic prescribing patterns for hidradenitis suppurativa between the emergency department and ambulatory care setting.比较急诊科和门诊护理环境中化脓性汗腺炎的抗生素处方模式。
PLoS One. 2025 May 19;20(5):e0310651. doi: 10.1371/journal.pone.0310651. eCollection 2025.
2
Advances in Microbiome-Based Therapeutics for Dermatological Disorders: Current Insights and Future Directions.基于微生物群的皮肤病治疗进展:当前见解与未来方向
Exp Dermatol. 2024 Dec;33(12):e70019. doi: 10.1111/exd.70019.
3
Physicochemical parameters and modes of interaction associated with the micelle formation of a mixture of tetradecyltrimethylammonium bromide and cefixime trihydrate: effects of hydrotropes and temperature.
与十四烷基三甲基溴化铵和三水合头孢克肟混合物胶束形成相关的物理化学参数及相互作用模式:助溶剂和温度的影响
RSC Adv. 2023 Oct 17;13(43):30429-30442. doi: 10.1039/d3ra04748b. eCollection 2023 Oct 11.
4
Innate immunity and microbial dysbiosis in hidradenitis suppurativa - vicious cycle of chronic inflammation.先天性免疫和微生物失调与化脓性汗腺炎-慢性炎症的恶性循环。
Front Immunol. 2022 Jul 28;13:960488. doi: 10.3389/fimmu.2022.960488. eCollection 2022.
5
Cutaneous Metastatic Breast Cancer Masked by Hidradenitis Suppurativa.被化脓性汗腺炎掩盖的皮肤转移性乳腺癌
Cureus. 2021 Jan 22;13(1):e12862. doi: 10.7759/cureus.12862.